...On Jan. 2, CRO Cyprotex acquired NAMSA's CeeTox Inc. division for about £630,000 ($1 million) in...
...for the year ended Sept. 30, 2013, and an operating loss of £900,000 ($1.4 million). Cyprotex plc...

...is available on Axion's high-throughput Maestro MEA drug screening system. Axion Biosystems , Atlanta, Ga. Cyprotex plc...

...18-month deal to improve Cyprotex's predictive toxicology ADMET services. The companies did not disclose details. Cyprotex plc...

...Sigma Aldrich's Sigma Life Science business granted Cyprotex a non-exclusive license to offer Sigma's transporter knockout...
...screening and safety studies. The assays were developed using CompoZr Zinc Finger Nuclease (ZFN) technology. Cyprotex...
...ATP-binding cassette sub-family C member 2 transporters. The companies could not be reached for details. Cyprotex plc...

...Preclinical CRO Cyprotex launched the CellCiphr Premier service for classifying cellular responses to drug exposure. The...
...toxicity markers from replicating and metabolically competent cells to identify early and late stage toxicities. Cyprotex plc...

...medicinal chemistry and Cyportex's ADME/PK services. Details were not disclosed (see BioCentury, Dec. 14, 2009). Cyprotex plc...

...launched its gADME service worldwide to determine the effect of genetic polymorphisms on drug pharmacokinetics. Cyprotex plc...

...Cyprotex's Cyprotex Discovery Ltd. subsidiary and Sygnature entered into an agreement to provide a discovery chemistry/...
...to provide a discovery chemistry/ DMPK service using Sygnature's medicinal chemistry and Cyprotex's ADME/PK services. Cyprotex plc...